Abstract PR-10: AXL limits the mobilization of cholesterol to regulate dendritic cell maturation and the immunogenic response to cancer
Meriem Belabed(Icahn School of Medicine at Mount Sinai), Miriam Mérad(Icahn School of Medicine at Mount Sinai), C. Matthias Wilk(Icahn School of Medicine at Mount Sinai), Leanna Troncoso(Icahn School of Medicine at Mount Sinai), Sourav Ghosh(Yale University), Matthew D. Park(Icahn School of Medicine at Mount Sinai), Laurent Yvan‐Charvet(Inserm), Daniel J. Puleston(Bloomberg (United States)), Jessica Le Bérichel(Icahn School of Medicine at Mount Sinai), Sreekumar Balan(Icahn School of Medicine at Mount Sinai), Nina Bhardwaj(Mount Sinai Hospital), Thomas U. Marron(Icahn School of Medicine at Mount Sinai), Elvin Wagenblast(Icahn School of Medicine at Mount Sinai), Nader Yatim(Institut Pasteur), Cédric M. Blouin(Centre National de la Recherche Scientifique), Nelson M. LaMarche(Icahn School of Medicine at Mount Sinai), Amanda Reid(Icahn School of Medicine at Mount Sinai), Brian D. Brown(Icahn School of Medicine at Mount Sinai), Christophe Lamaze(Centre National de la Recherche Scientifique), Miguel Quijada‐Álamo(Icahn School of Medicine at Mount Sinai), Chang Moon(Icahn School of Medicine at Mount Sinai), Carla V. Rothlin(Yale University), Jesse Boumelha(The Francis Crick Institute), Camillia S. Azimi(Icahn School of Medicine at Mount Sinai), Grace Freed(Icahn School of Medicine at Mount Sinai), Raphaël Mattiuz(Icahn School of Medicine at Mount Sinai), Steven T. Chen(Hess (United States)), Kristen J. Radford(Translational Research Institute)
Cited by 0
Related Papers
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Immunology of COVID-19: Current State of the Science
|Immunity|2020|1.8k